Bank of Montreal’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bank of Montreal’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-38,400	Closed	-$1.01M	–	3843
2026 Q1	$1.01M	Buy	+38,400	New	+$1.12M	﹤0.01%	2031
2022 Q3	–	Sell	-25,000	Closed	-$856K	–	4064
2022 Q2	$856K	Hold	25,000	–	–	﹤0.01%	2407
2022 Q1	$1.24M	Hold	25,000	–	–	﹤0.01%	2201
2021 Q4	$1.57M	Buy	+25,000	New	+$1.73M	﹤0.01%	1703
2021 Q1	–	Sell	-15,000	Closed	-$1.57M	–	5052
2020 Q4	$1.57M	Buy	+15,000	New	+$1.2M	﹤0.01%	1958

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of Montreal's ARKG Position: Q2 2026 in Review

Bank of Montreal increased its ARK Genomic Revolution ETF (ARKG) stake by 3,217% in Q2 2026, buying an estimated $4.48M and bringing the position to 145,204 shares worth $6.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Bank of Montreal first reported a position in ARKG in Q1 2018 and has held it in 34 quarters since. 273 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Bank of Montreal held 145,204 shares of ARK Genomic Revolution ETF worth $6.11M as of Q2 2026.
Bank of Montreal bought 140,827 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $4.48M.
ARK Genomic Revolution ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1310 holding.
Bank of Montreal first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 34 quarters since.
273 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.